Now in its 10th edition,
World Drug Safety Americas 2018
is the global leading drug safety strategy-led event for pharma and biotech organisations.
Since its launch in 2008, ourconference has stood out from the crowd.
The event has always provided a unique forum for industry and partners to learn about the latest developments in drug safety and how they can tackle day-to-day critical challenges. We’ve kept this as our core concept ever since and tailored our program year after year to address exciting and emerging topics of highest relevance to the industry at that time.
Going into 2018, drug safety is still an important topic as priorities change and the regulatory backdrop continues to evolve. Now is the time to improve patient safety strategies to exceed expectations. The event builds on the success to date, covering new technologies in drug safety and offering the most innovative and freshest case studies on drug safety projects.
2018 is set to be bigger and better than ever before.
The meeting has a high proportion of pharma organisations year on year. We attract the biggest industry players from large, small and medium pharma / biotech organisations. We will have even more perspectives including regional specialists, technology partners, consultancies, CROs and global directors in attendance.
This is the place to meet global pioneers who are shaping the pharmacovigilance industry.
Over 250 attendees were there in 2017: from the regulatory, biopharma, CRO, technology and consultancy community.